Tate & Lyle Ventures

Tate & Lyle Ventures is a venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United KingdomUnited Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Tate & Lyle Ventures is a venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing HealthChanging Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Tate & Lyle Ventures is a venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve BiosystemsEvolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Tate & Lyle Ventures is a venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, EnglandEngland, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Tate & Lyle Ventures is a venture capital firmventure capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Tate & Lyle Ventures is a venture capital firm in LondonLondon that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Tate & Lyle Ventures is a venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, AllylixAllylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Tate & Lyle Ventures is a venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.